ArticleAntibiotics (Basel, Switzerland)2019
The Inc FII Plasmid and its Contribution in the Transmission of
Article in Antibiotics (Basel, Switzerland), 2019. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 16 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
16 citing papers in PubMed, 24 citations in OpenAlex.
- Clinically Significant Carbapenemases in Gram-Negative Pathogens: Molecular Diversity and Advances in β-Lactamase Inhibitor Therapy.Antibiotics (Basel, Switzerland) · 2026Review
- The emergence and spread ofFrontiers in cellular and infection microbiology · 2025Article
- Review
- Emergence and dissemination of multidrug-resistantFrontiers in cellular and infection microbiology · 2025Article
- A Newly Incompatibility F Replicon Allele (FIB81) in Extensively Drug-ResistantInternational journal of molecular sciences · 2024Article
- The emergence of carbapenem-resistance and New Delhi metallo-β-lactamase-1 (Iranian journal of microbiology · 2024Article
- pKpQIL-like plasmid contributes to the dissemination ofIranian journal of microbiology · 2023Article
- Genotypic Characterization of Carbapenem-ResistantPathogens (Basel, Switzerland) · 2023Article
- First Emergence of NDM-5 and OqxAB Efflux Pumps Among Multidrug-ResistantInfection and drug resistance · 2023Article
- Molecular Epidemiology and Risk Factors of Carbapenem-Resistant Klebsiella Pneumoniae Bloodstream Infections in Wuhan, China.Current medical science · 2022Article
- Phenotype-genotype correlations among carbapenem-resistant Enterobacterales recovered from four Egyptian hospitals with the report of SPM carbapenemase.Antimicrobial resistance and infection control · 2022Article
- Carbapenem-ResistantInfection and drug resistance · 2022Article
- Landscape of Multidrug-Resistant Gram-Negative Infections in Egypt: Survey and Literature Review.Infection and drug resistance · 2021Article
- Molecular Epidemiology ofInfection and drug resistance · 2021Article
- Co-existence of a novel plasmid-mediated efflux pump with colistin resistance geneEmerging microbes & infections · 2020Article
- Antibiotics and Environment.Antibiotics (Basel, Switzerland) · 2020Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors at 3 institutions in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
The emergence of
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.